pamidronate has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Illidge, TM | 1 |
| Hussey, M | 1 |
| Godden, CW | 1 |
1 other study available for pamidronate and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
Topics: Adult; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Infant, Newbo | 1996 |